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Following publication of the original article [1] it was
brought to our attention that some of the data within
the article required correction.
Hence, please note that in the second paragraph of the
section headed ‘Three-state markov model and transition
probabilities’ there is a sentence which reads as:
“At the end of 12 weeks, approximately 65 % of
patients in the CCO + SSD group were considered
healed compared to 47 % in the Control group.”
However, this should read as:
“At the end of 12 weeks, approximately 47 % of
patients in the CCO + SSD group were considered
healed compared to 32 % in the Control group.”
This alteration does not affect the methodology or results.
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